BATON ROUGE, La.--(BUSINESS WIRE)--
Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health and
hospice companies, today announced that William F. Borne, Chief
Executive Officer and Ronald A. LaBorde, President and Chief Financial
Officer will present at the 30th Annual JP Morgan Healthcare
Conference in San Francisco, CA on Wednesday, January 11, 2012.
The presentation will begin at 4:00 p.m. Pacific/7:00 p.m. Eastern. To
access a live webcast of the Amedisys presentation, please log on
through our website at http://investors.amedisys.com.
About Amedisys, Inc.
Amedisys, Inc. (NASDAQ: AMED) is a leading health care company focused
on bringing home the continuum of care. Amedisys delivers personalized
health care services to patients and their families, in the comfort of
patients’ homes, with approximately 10 million patient care and
education encounters per year. Amedisys has two divisions, home health
care and hospice. The Company’s state-of-the-art advanced chronic care
management programs and leading-edge technology enables it to deliver
quality care based upon the latest evidence-based best practices.
Amedisys is a recognized innovator, being one of the first in the
industry to equip its clinicians with point-of-care laptop technology
and referring physicians with an internet portal that enables real-time
coordination of patient care seamlessly. Amedisys also has the
industry’s first-ever nationwide Care Transitions program. Amedisys Care
Transitions is designed to reduce unnecessary hospital readmissions
through patient and caregiver health coaching and care coordination,
which starts in the hospital and continues throughout completion of the
patient’s home health plan of care. For more information about the
Company, please visit: www.amedisys.com.
Our company website address is www.amedisys.com.
We use our website as a channel of distribution for important company
information. Important information, including press releases, analyst
presentations and financial information regarding the Company is
routinely posted on and accessible on the “Investor Relations” subpage
of our website, which is accessible by clicking on the tab labeled
“Investors” on our website home page. We will also use our website to
expedite public access to time-critical information regarding the
Company in advance of or in lieu of distributing a press release or a
filing with the Securities and Exchange Commission (“SEC”) disclosing
the same information. In addition, we make available on the Investor
Relations subpage of our website (under the link “SEC filings”) free of
charge our annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and
any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of our
Certificate of Incorporation and Bylaws, our Code of Ethical Business
Conduct and the charters for the Audit, Compensation and Nominating and
Governance Committees of our Board are also available on the Investor
Relations subpage of our website (under the link “Corporate Governance”).
Amedisys, Inc.
Kevin B. LeBlanc, 225-299-3391
Director
of Investor Relations
[email protected]
Source: Amedisys, Inc.